Natalie Sacks's Net Worth
$2.2 Million
Who is Natalie Sacks?
Natalie Sacks has an estimated net worth of $2.2 Million. This is based on reported shares across multiple companies, which include Zymeworks Inc., Caribou Biosciences, Inc., ADURO BIOTECH, INC., Harpoon Therapeutics, Inc., and Zymeworks Inc..
SEC CIK
Natalie Sacks's CIK is 0001683811
Past Insider Trading and Trends
2020 was Natalie Sacks's most active year for acquiring shares with 16 total transactions. Natalie Sacks's most active month to acquire stocks was the month of December. 2020 was Natalie Sacks's most active year for disposing of shares, totalling 28 transactions. Natalie Sacks's most active month to dispose stocks was the month of March. 2019 saw Natalie Sacks paying a total of $117,819.00 for 65,575 shares, this is the most they've acquired in one year. In 2019 Natalie Sacks cashed out on 111,150 shares for a total of $771,066.48, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Zymeworks Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caribou Biosciences, Inc. (CRBU) Snapshot price: $6.7003
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADURO BIOTECH, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +94.00% | 84.17K |
$6.50 | -$19,679.88 | 173.72K |
Sep 12 - Sep 13
| |||
Form 4
| -4.79% | -4.50K |
$7.13 | -$32,099.11 | 89.55K |
Sep 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +20.98% | 16.31K |
—
|
—
| 94.05K |
Dec 11
| |||
Form 4
| +72.32% | 32.63K |
—
|
—
| 77.74K |
Sep 12
| |||
Form 4
| -9.77% | -4.88K |
$11.71 | -$57,196.02 | 45.12K |
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Sep 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) Snapshot price: $22.34
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$8.45 | -$19,251.93 | 45.75K |
Scheduled
|
May 18
| ||
Form 4
|
—
|
0
|
$7.10 | -$57,950.06 | 45.75K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$7.09 | -$15,105.59 | 45.75K |
Scheduled
|
Apr 16 - Apr 17
| ||
Form 4
|
—
|
0
|
$7.09 | -$45,300.31 | 45.75K |
Scheduled
|
Apr 13
| ||
Form 4
|
—
|
0
|
$7.06 | -$12,548.58 | 45.75K |
Scheduled
|
Apr 6 - Apr 7
| ||
Form 4
|
—
|
0
|
$7.06 | -$15,027.48 | 45.75K |
Scheduled
|
Mar 16 - Mar 17
| ||
Form 4
|
—
|
0
|
$8.40 | -$73,174.56 | 45.75K |
Scheduled
|
Mar 2
| ||
Form 4
|
—
|
0
|
$8.56 | -$19,590.48 | 45.75K |
Scheduled
|
Feb 18
| ||
Form 4
|
—
|
0
|
$8.01 | -$68,655.33 | 45.75K |
Scheduled
|
Jan 31 - Feb 3
| ||
Form 4
|
—
|
0
|
$8.53 | -$19,500.44 | 45.75K |
Scheduled
|
Jan 16
| ||
Form 4
|
—
|
0
|
$8.15 | -$70,249.33 | 45.75K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$9.57 | -$22,663.05 | 45.75K |
Scheduled
|
Dec 16
| ||
Form 4
|
—
|
0
|
$10.05 | -$92,400.36 | 45.75K |
Scheduled
|
Dec 2
| ||
Form 4
|
—
|
0
|
$7.74 | -$205,269.74 | 45.75K |
Scheduled
|
Nov 18
| ||
Form 4
|
—
|
0
|
$7.65 | -$64,350.50 | 45.75K |
Scheduled
|
Nov 1
| ||
Form 4
|
—
|
0
|
$7.68 | -$268,563.83 | 45.75K |
Scheduled
|
Oct 14 - Oct 15
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zymeworks Inc. (ZYME) Snapshot price: $11.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
| No matching records found | |||||||||